Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Market Cap	6.10B
Revenue (ttm)	1.24B
Net Income (ttm)	468.80M
Shares Out	45.05M
EPS (ttm)	10.37
PE Ratio	13.06
Forward PE	n/a
Dividend	11.00 (8.15%)
Ex-Dividend Date	Jul 3, 2025

Volume	30,944
Average Volume	34,393
Open	136.50
Previous Close	135.50
Day's Range	135.00 - 136.50
52-Week Range	127.50 - 182.50
Beta	0.06
RSI	41.87
Earnings Date	May 15, 2025

About Dr. Wu Skincare

Dr. Wu Skincare Co., Ltd. engages in the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally. The company offers collagen peptide powders, cleansers, masks, toners, serums, hydrating lotions/creams/gels, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company was incorporated in 2003 and is based...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2003
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6523

Financial Performance

In 2024, Dr. Wu Skincare's revenue was 1.24 billion, an increase of 9.20% compared to the previous year's 1.14 billion. Earnings were 476.25 million, an increase of 12.13%.